Advertisement

The UK Royal College of Pathologists (RCPath) Terminology for Reporting Thyroid FNA Cytology and Its Importance in Multidisciplinary Patient Management

  • David N. PollerEmail author
Chapter

Abstract

The UK Royal College of Pathologists (RCPath) ‘Thy’ terminology for reporting thyroid FNA cytology is a well-established national and also an international terminology system for cytology reporting which aligns with other international terminology systems: The Bethesda System for Reporting Thyroid FNA Cytopathology and the Italian, Japanese and Australian systems. There are now multiple peer-reviewed publications in the English language literature that utilise the UK RCPath Thyroid FNA terminology, and publications have now confirmed good interobserver reproducibility and its validity for patient management with risk(s) of malignancy and positive predictive value(s) established by audit for all ‘Thy’ categories of FNA, Thy1–Thy5. In the UK RCPath system, multidisciplinary management is emphasised, and the UK RCPath ‘Thy’ terminology is embedded in the multidisciplinary management and treatment recommendations in the 2014 British Thyroid Association Guidelines for the Management of Thyroid Cancer.

Keywords

Thyroid Cytology Fine needle aspiration Terminology UK 

References

  1. 1.
    Cross P, Chandra A, Giles T, Johnson S, Kocjan G, Poller D, Stephenson T. Guidance on the reporting of thyroid cytology specimens. London: Royal College of Pathologists; 2016.Google Scholar
  2. 2.
    Perros P, Boelaert K, Colley S, Evans C, Evans RM, Gerrard Ba G, et al. Guidelines for the management of thyroid cancer. Clin Endocrinol. 2014;81(Suppl 1):1–122.CrossRefGoogle Scholar
  3. 3.
    Asioli S, Maletta F, Pacchioni D, Lupo R, Bussolati G. Cytological detection of papillary thyroid carcinomas by nuclear membrane decoration with emerin staining. Virchow Archiv. 2010;457(1):43–51.CrossRefGoogle Scholar
  4. 4.
    Brophy C, Mehanna R, McCarthy J, Tuthill A, Murphy MS, Sheahan P. Outcome of subclassification of indeterminate (Thy-3) thyroid cytology into Thy-3a and Thy-3f. Eur Thyr J. 2015;4(4):246–51.CrossRefGoogle Scholar
  5. 5.
    Calo PG, Lai ML, Guaitoli E, Pisano G, Favoriti P, Nicolosi A, et al. Difficulties in the diagnosis of thyroid paraganglioma: a clinical case. La Clin Terapeut. 2013;164(1):e35–9.Google Scholar
  6. 6.
    Cantisani V, Maceroni P, D’Andrea V, Patrizi G, Di Segni M, De Vito C, et al. Strain ratio ultrasound elastography increases the accuracy of colour-Doppler ultrasound in the evaluation of Thy-3 nodules. A bi-centre university experience. Eur Radiol. 2016;26(5):1441–9.PubMedCrossRefGoogle Scholar
  7. 7.
    Caraci P, Fulcheri A, Ondolo C, Laino F, Volante M, Aversa S. Hyalinizing trabecular tumor of the thyroid: a case report. Head Neck Pathol. 2011;5(4):423–7.PubMedPubMedCentralCrossRefGoogle Scholar
  8. 8.
    Collins J, Rossi ED, Chandra A, Ali SZ. Terminology and nomenclature schemes for reporting thyroid cytopathology: an overview. Semin Diagn Pathol. 2015;32(4):258–63.PubMedCrossRefGoogle Scholar
  9. 9.
    Gill G, Kalyanasundaram K, Varughese G, Wilson P, Varadhan L. Fine needle aspiration cytology vs. the postoperative histology—the continuing need for multi-disciplinary approach? Exp Clin Endocrinol Diabetes. 2016;124(7):448–51.PubMedCrossRefGoogle Scholar
  10. 10.
    Giusti M, Campomenosi C, Gay S, Massa B, Silvestri E, Monti E, et al. The use of semi-quantitative ultrasound elastosonography in combination with conventional ultrasonography and contrast-enhanced ultrasonography in the assessment of malignancy risk of thyroid nodules with indeterminate cytology. Thyroid Res. 2014;7(1):9.PubMedPubMedCentralCrossRefGoogle Scholar
  11. 11.
    Giusti M, Massa B, Balestra M, Calamaro P, Gay S, Schiaffino S, et al. Retrospective cytological evaluation of indeterminate thyroid nodules according to the British Thyroid Association 2014 classification and comparison of clinical evaluation and outcomes. J Zhejiang Univ Sci B. 2017;18(7):555–66.PubMedPubMedCentralCrossRefGoogle Scholar
  12. 12.
    Glynn N, Hannon MJ, Lewis S, Hillery P, Al-Mousa M, Hill AD, et al. Utility of repeat cytological assessment of thyroid nodules initially classified as benign: clinical insights from multidisciplinary care in an Irish tertiary referral centre. BMC Endocr Disord. 2016;16(1):45.PubMedPubMedCentralCrossRefGoogle Scholar
  13. 13.
    Kocjan G, Chandra A, Cross PA, Giles T, Johnson SJ, Stephenson TJ, et al. The interobserver reproducibility of thyroid fine-needle aspiration using the UK Royal College of Pathologists’ classification system. Am J Clin Pathol. 2011;135(6):852–9.PubMedCrossRefGoogle Scholar
  14. 14.
    Lakhani R, Rourke T, Jefferis A, Perry L, Ghiacy S, Wood S. Thy3 cytology: what to do next? Ann R Coll Surg Engl. 2011;93(3):225–8.PubMedPubMedCentralCrossRefGoogle Scholar
  15. 15.
    Liu ZW, Fox R, Unadkat S, Farrell R. A retrospective study of ultrasound and FNA cytology investigation of thyroid nodules: working towards combined risk stratification. Eur Arch Otorhinolaryngol. 2017;274(6):2537–40.PubMedCrossRefGoogle Scholar
  16. 16.
    Lobo C, McQueen A, Beale T, Kocjan G. The UK Royal College of Pathologists thyroid fine-needle aspiration diagnostic classification is a robust tool for the clinical management of abnormal thyroid nodules. Acta Cytol. 2011;55(6):499–506.PubMedCrossRefGoogle Scholar
  17. 17.
    Mehanna R, Murphy M, McCarthy J, O’Leary G, Tuthill A, Murphy MS, et al. False negatives in thyroid cytology: impact of large nodule size and follicular variant of papillary carcinoma. Laryngoscope. 2013;123(5):1305–9.PubMedCrossRefGoogle Scholar
  18. 18.
    Mitchell AL, Gandhi A, Scott-Coombes D, Perros P. Management of thyroid cancer: United Kingdom National Multidisciplinary Guidelines. J Laryngol Otol. 2016;130(S2):S150–s60.PubMedPubMedCentralCrossRefGoogle Scholar
  19. 19.
    Montgomery J, Hendry J, Van der Horst C, Hunter MA, MacKenzie K, Hilmi O. Cytological accuracy and radiological staging in patients with thyroid cancer in Glasgow. Eur Arch Otorhinolaryngol. 2016;273(9):2741–6.PubMedCrossRefGoogle Scholar
  20. 20.
    Parkinson D, Aziz S, Bentley R, Johnson SJ. Thyroid cytology-histology correlation using the RCPath terminology for thyroid cytology reporting. J Clin Pathol. 2017;70(8):648–55.PubMedCrossRefGoogle Scholar
  21. 21.
    Pelizzo MR, Conti C, Pennelli G, Bellan E, Cook GJ, Wong KK, et al. Thyroid paraganglioma: our experience and systematic review of the literature on a rare tumor. Am J Clin Oncol. 2018;41(4):416–23.  https://doi.org/10.1097/coc.0000000000000295.PubMedCrossRefGoogle Scholar
  22. 22.
    Petrone L, Mannucci E, De Feo ML, Parenti G, Biagini C, Panconesi R, et al. A simple ultrasound score for the identification of candidates to fine needle aspiration of thyroid nodules. J Endocrinol Investig. 2012;35(8):720–4.Google Scholar
  23. 23.
    Poller DN, Baloch ZW, Fadda G, Johnson SJ, Bongiovanni M, Pontecorvi A, et al. Thyroid FNA: new classifications and new interpretations. Cancer Cytopathol. 2016;124(7):457–66.PubMedCrossRefGoogle Scholar
  24. 24.
    Poller DN, Glaysher S, Agrawal A, Caldera S, Kim D, Yiangou C. BRAF V600 co-testing in thyroid FNA cytology: short-term experience in a large cancer centre in the UK. J Clin Oathol. 2014;67(8):684–9.CrossRefGoogle Scholar
  25. 25.
    Poller DN, Kandaswamy P. A simplified economic approach to thyroid FNA cytology and surgical intervention in thyroid nodules. J Clin Pathol. 2013;66(7):583–8.PubMedCrossRefGoogle Scholar
  26. 26.
    Pupilli C, Pinzani P, Salvianti F, Fibbi B, Rossi M, Petrone L, et al. Circulating BRAFV600E in the diagnosis and follow-up of differentiated papillary thyroid carcinoma. J Clin Endocrinol Metab. 2013;98(8):3359–65.PubMedCrossRefGoogle Scholar
  27. 27.
    Raggiunti B, Capone F, Franchi A, Fiore G, Filipponi S, Colagrande V, et al. Ultrasoundelastography: can it provide valid information for differentiation of benign and malignant thyroid nodules? J Ultrasound. 2011;14(3):136–41.PubMedPubMedCentralCrossRefGoogle Scholar
  28. 28.
    Rago T, Scutari M, Latrofa F, Loiacono V, Piaggi P, Marchetti I, et al. The large majority of 1520 patients with indeterminate thyroid nodule at cytology have a favorable outcome, and a clinical risk score has a high negative predictive value for a more cumbersome cancer disease. J Clin Endocrinol Metab. 2014;99(10):3700–7.PubMedCrossRefGoogle Scholar
  29. 29.
    Rago T, Scutari M, Loiacono V, Santini F, Tonacchera M, Torregrossa L, et al. Low elasticity of thyroid nodules on ultrasound elastography is correlated with malignancy, degree of fibrosis, and high expression of galectin-3 and fibronectin-1. Thyroid. 2017;27(1):103–10.PubMedCrossRefGoogle Scholar
  30. 30.
    Rodrigues AC, Penna G, Rodrigues E, Castro P, Sobrinho-Simoes M, Soares P. The genetics of papillary microcarcinomas of the thyroid: diagnostic and prognostic implications. Curr Genom. 2017;18(3):244–54.CrossRefGoogle Scholar
  31. 31.
    Sciacchitano S, Lavra L, Ulivieri A, Magi F, Porcelli T, Amendola S, et al. Combined clinical and ultrasound follow-up assists in malignancy detection in Galectin-3 negative Thy-3 thyroid nodules. Endocrine. 2016;54(1):139–47.PubMedCrossRefGoogle Scholar
  32. 32.
    Sheahan P, Mohamed M, Ryan C, Feeley L, Fitzgerald B, McCarthy J, et al. Follicular variant of papillary thyroid carcinoma: differences from conventional disease in cytologic findings and high-risk features. JAMA Otolaryngol Head Neck Surg. 2014;140(12):1117–23.PubMedCrossRefGoogle Scholar
  33. 33.
    Sidoti M, Marino G, Resmini E, Augeri C, Cappi C, Cavallero D, et al. The rational use of fine needle aspiration biopsy (FNAB) in diagnosing thyroid nodules. Minerva Endocrinol. 2006;31(2):159–72.PubMedGoogle Scholar
  34. 34.
    Trimboli P, Bongiovanni M, Rossi F, Guidobaldi L, Crescenzi A, Ceriani L, et al. Differentiated thyroid cancer patients with a previous indeterminate (Thy 3) cytology have a better prognosis than those with suspicious or malignant FNAC reports. Endocrine. 2015;49(1):191–5.PubMedCrossRefGoogle Scholar
  35. 35.
    Trimboli P, Crescenzi A. Thyroid core needle biopsy: taking stock of the situation. Endocrine. 2015;48(3):779–85.PubMedCrossRefGoogle Scholar
  36. 36.
    Tysome JR, Chandra A, Chang F, Puwanarajah P, Elliott M, Caroll P, et al. Improving prediction of malignancy of cytologically indeterminate thyroid nodules. Br J Surg. 2009;96(12):1400–5.PubMedCrossRefGoogle Scholar
  37. 37.
    Johnson SJ, Hardy SA, Roberts C, Bourn D, Mallick U, Perros P. Pilot of BRAF mutation analysis in indeterminate, suspicious and malignant thyroid FNA cytology. Cytopathology. 2014;25(3):146–54.PubMedCrossRefGoogle Scholar
  38. 38.
    Johnson SJ, Stephenson TJ, Poller DN. NIFTP addendum to the RCPath dataset for thyroid cancer histopathology reports. London: Royal College of Pathologists; 2016.Google Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2019

Authors and Affiliations

  1. 1.Department of PathologyQueen Alexandra HospitalCoshamUK

Personalised recommendations